drug pricing transparency Archives - Pharma Marketing Network

Home Tags Drug pricing transparency

The Pricing Narrative Shift: Why Pharma Can No Longer Control the...

Donna Pacheco - April 1, 2026

The PBM Backlash: How Pharma Marketing Must Respond to the New...

Donna Pacheco - March 26, 2026

Marketing in a Price-Control Era: How to Tell a Value Story...

Donna Pacheco - February 25, 2026

Pharmaceutical executive, doctor, and government official discussing drug pricing over money and medical tools, symbolizing pharma pricing communication

How Pharma Marketers Should Communicate Drug Price Negotiations

Donna Pacheco - January 1, 2026

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Pharmaceutical portfolio strategy concept showing connected drug products, analytics charts, and digital healthcare icons under a magnifying glass

The Portfolio Fragmentation Challenge: How Marketers Can Maintain a Clear Story...

April 24, 2026

Split image showing a stopwatch symbolizing speed and a compliance checklist with medical tools representing safety in pharma marketing

Speed vs Safety: How Pharma Marketers Can Compete in a Faster,...

April 23, 2026

Balance scale comparing pharmaceutical demand and clinical evidence with GLP-1 medications and research materials

The Demand–Evidence Gap: What GLP-1 Growth Teaches Pharma Marketers About Responsible...

April 22, 2026